<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.9.2 (http://www.squarespace.com/) on Thu, 11 Mar 2010 10:46:31 GMT--><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0"><channel><title>The Melanoma Blog</title><link>http://themelanomablog.com/blogs/</link><description>First hand comments on surgical adjuvant treatment and therapy of metastatic treatment by Lynn Spitler, M.D., Director, Northern California Melanoma Center</description><lastBuildDate>Wed, 12 Aug 2009 21:34:31 +0000</lastBuildDate><copyright></copyright><language>en-US</language><generator>Squarespace Site Server v5.9.2 (http://www.squarespace.com/)</generator><item><title>NEW CLINICAL TRIAL OPEN</title><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Wed, 12 Aug 2009 17:15:39 +0000</pubDate><link>http://themelanomablog.com/blogs/2009/8/12/new-clinical-trial-open.html</link><guid isPermaLink="false">145102:1326503:4885725</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-4885725.xml</wfw:commentRss></item><item><title>2009 AJCC/UICC Melanoma Staging System</title><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Sat, 23 May 2009 19:14:59 +0000</pubDate><link>http://themelanomablog.com/blogs/2009/5/23/2009-ajccuicc-melanoma-staging-system.html</link><guid isPermaLink="false">145102:1326503:4067332</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-4067332.xml</wfw:commentRss></item><item><title>Updated Melanoma Patient Web Resources &amp; Links 1.19.09</title><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Tue, 20 Jan 2009 00:19:26 +0000</pubDate><link>http://themelanomablog.com/blogs/2009/1/19/updated-melanoma-patient-web-resources-links-11909.html</link><guid isPermaLink="false">145102:1326503:2868933</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-2868933.xml</wfw:commentRss></item><item><title>Report at 2008 ASCO Meeting Indicates Administration of Vaccine as Adjuvant Therapy of Melanoma Is Ineffective And May Be Harmful</title><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Sun, 10 Aug 2008 15:26:04 +0000</pubDate><link>http://themelanomablog.com/blogs/2008/8/10/report-at-2008-asco-meeting-indicates-administration-of-vacc.html</link><guid isPermaLink="false">145102:1326503:2112712</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-2112712.xml</wfw:commentRss></item><item><title>Event: The Journey Through Cancer &amp; The Seven Levels of Healing</title><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Thu, 28 Feb 2008 06:29:54 +0000</pubDate><link>http://themelanomablog.com/blogs/2008/2/28/event-the-journey-through-cancer-the-seven-levels-of-healing.html</link><guid isPermaLink="false">145102:1326503:1622328</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-1622328.xml</wfw:commentRss></item><item><title>STILL ALIVE by HANK GARDSTEIN M.D.</title><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Wed, 29 Aug 2007 17:25:05 +0000</pubDate><link>http://themelanomablog.com/blogs/2007/8/29/still-alive-by-hank-gardstein-md.html</link><guid isPermaLink="false">145102:1326503:1231434</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-1231434.xml</wfw:commentRss></item><item><title>2007 ASCO MEETING REPORT ON LONG-TERM ADJUVANT PEGYLATED INTERFERON-ALPHA2B</title><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Tue, 26 Jun 2007 19:02:54 +0000</pubDate><link>http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-long-term-adjuvant-pegylated-int.html</link><guid isPermaLink="false">145102:1326503:1120388</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-1120388.xml</wfw:commentRss></item><item><title>2007 ASCO MEETING - REPORT ON IMMUNOLOGIC EFFECTS OF GM-CSF</title><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Tue, 26 Jun 2007 18:32:43 +0000</pubDate><link>http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-immunologic-effects-of-gm-csf.html</link><guid isPermaLink="false">145102:1326503:1120356</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-1120356.xml</wfw:commentRss></item><item><title>2007 ASCO MEETING SUMMARY</title><category>Meetings</category><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Fri, 15 Jun 2007 20:19:34 +0000</pubDate><link>http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting-summary.html</link><guid isPermaLink="false">145102:1326503:1103648</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-1103648.xml</wfw:commentRss></item><item><title>2007 ASCO MEETING</title><dc:creator>Dr Lynn Spitler</dc:creator><pubDate>Fri, 15 Jun 2007 20:19:32 +0000</pubDate><link>http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting.html</link><guid isPermaLink="false">145102:1326503:1103646</guid><wfw:commentRss>http://themelanomablog.com/blogs/rss-comments-entry-1103646.xml</wfw:commentRss></item></channel></rss>